Androgenetic alopecia in COVID-19: Compared to age-matched epidemiologic studies and hospital outcomes with or without the Gabrin sign

Ítems similars

• Reply to comment on: The Gabrin sign
  per: Wambier, Carlos Gustavo, et al.
  Publicat: (2021)
• Androgenetic alopecia present in the majority of patients hospitalized with COVID-19: The “Gabrin sign”
  per: Wambier, Carlos Gustavo, et al.
  Publicat: (2020)
• What does androgenetic alopecia have to do with COVID‐19? An insight into a potential new therapy
  per: Goren, Andy, et al.
  Publicat: (2020)
• Comment on: The Gabrin sign
  per: Trüeb, Ralph M., et al.
  Publicat: (2021)
• Male balding as a major risk factor for severe COVID-19: A possible role for targeting androgens and transmembrane protease serine 2 to protect vulnerable individuals
  per: Wambier, Carlos Gustavo, et al.
  Publicat: (2020)